¿¡½ºÅ¸Á¦Á¤ ESTASE DRG.[Ammonium Glycyrrhizinate , Biodiastase 700G , Carnitine HCl , Ox bile extract , Thiamine Hydrochloride]
ÀϹÝÀǾàǰ | »èÁ¦
¾Ë¸²:
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù.
Àü¹®/ÀϹÝ
ÀϹÝ
¹é»öÀÇ À广Çü ´çÀÇÁ¤Á¦ÀÓ.
Á¦Á¶È¸»ç
ÇϳªÁ¦¾à(ÁÖ)
ÆÇ¸Åȸ»ç
ÇϳªÁ¦¾à(ÁÖ)
Çã°¡Á¤º¸
ÃëÇÏ
(2020.07.01)
BIT ¾àÈ¿ºÐ·ù
¼ÒÈÁ¦ (Digestants)
º¹ÁöºÎºÐ·ù
233[°ÇÀ§¼ÒÈÁ¦ ]
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå
657801370[A20401851] \0 ¿ø/1Á¤(2013.10.01) (ÇöÀç¾à°¡) \0 ¿ø/1Á¤(2006.07.01) (º¯°æÀü¾à°¡)
ATCÄÚµå
DIGESTIVES, INCL. ENZYMES / A09A
NDCÄÚµå
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
¼ººÐ / ÇÔ·®
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
÷°¡Á¦
¹Ì°áÁ¤¼¿·ê·Î¿À½º ,
¹é´ç ,
»êȸ¶±×³×½· ,
»êÈÆ¼Åº ,
½ºÅ׾Ƹ°»ê¸¶±×³×½· ,
ÀλêÀϼö¼ÒÄ®½· ,
Á©¶óƾ ,
ħ°Åº»êÄ®½· ,
Ä«¸£³ª¿ì¹Ù³³ ,
Æú¸®¿¡Ä¥·»±Û¸®ÄÝ6000 ,
È÷µå·Ï½ÃÇÁ·ÎÇʸÞÄ¥¼¿·ê·Î¿À½º2910
À¯·áȸ¿ø °áÀç½Ã ¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸ ¸¦
ÀÌ¿ë ÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
À¯·áÁ¤º¸¸ñ·Ï Àº Àü¹®È¸¿ø À¸·Î
·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
Çã°¡Á¤º¸
Ç׸ñ
³»¿ë
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå »óÇѱݾ×
657801370[A20401851]
[º¸ÇèÄڵ忡 µû¸¥ ¾àǰ±âº»Á¤º¸ Á÷Á¢Á¶È¸]
\0 ¿ø/1Á¤(2013.10.01) (ÇöÀç¾à°¡)
\0 ¿ø/1Á¤(2006.07.01)(º¯°æÀü¾à°¡)
[»óº´ÄÚµåÁ¶È¸]
[Áúº´ÄÚµåÁ¶È¸]
ºü¸¥Á¶È¸
Á¦Ç°¼º»ó
¹é»öÀÇ À广Çü ´çÀÇÁ¤Á¦ÀÓ. [Á¦ÇüÁ¤º¸ È®ÀÎ]
Æ÷À塤À¯Åë´ÜÀ§
1000DRG
Æ÷À塤ÄÚµå´ÜÀ§
¾àǰ±Ô°Ý
´ÜÀ§
Æ÷ÀåÇüÅÂ
´ëÇ¥ÄÚµå
Ç¥ÁØÄÚµå
ºñ°í
50¹Ð¸®±×·¥
120 Á¤
º´
8806578013709
8806578013716
ÁÖ¼ººÐÄÚµå
276500ATB
[µ¿ÀÏÇÑ ÁÖ¼ººÐÄڵ带 °¡Áø ¿À¸®Áö³¯ ¶Ç´Â Á¦³×¸¯ ÀǾàǰ Á¶È¸]
Çã°¡»çÇ× ¿ø¹®Á¶È¸
[Çã°¡»çÇ× ¿ø¹®Á¶È¸]
È¿´ÉÈ¿°ú
[ÀûÀÀÁõ º° °Ë»ö]
¼ÒȺҷ® , ½Ä¿å°¨Åð (½Ä¿åºÎÁø ), ¼ÒȺҷ® À¸·Î ÀÎÇÑ À§ºÎÆØ¸¸°¨, °ú½Ä, ½Äü(À§Ã¼), ¼ÒÈÃËÁø, ±¸¿ª , ±¸Åä
¿ë¹ý¿ë·®
* Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù.
[󹿾à¾î]
¿ë¹ý¿ë·® ¿ë¹ý¿ë·®
¼ºÀÎ 1ȸ 1Á¤, 1ÀÏ 3ȸ ½ÄÈÄ¿¡ º¹¿ë
½ÅÁßÅõ¿©
1) Ç÷¾ÐÀÌ ³ôÀº »ç¶÷, °í·ÉÀÚ ,
2) ½ÉÀå ¶Ç´Â ½ÅÀå¿¡ Àå¾Ö°¡ Àִ ȯÀÚ
3) ºÎÁ¾ ÀÌ Àִ ȯÀÚ
4) ÀÇ»çÀÇ Ä¡·á¸¦ ¹Þ°í Àִ ȯÀÚ
ÀÌ»ó¹ÝÀÀ
1) ÀÌ ¾àÀ» º¹¿ëÇÔÀ¸·Î½á ¼Òº¯·®ÀÌ °¨¼ÒÇϰí, ¾ó±¼°ú ¼Õ¹ßÀÌ º×°í, ¼ÕÀÌ ±»¾îÁö°í, Ç÷¾ÐÀÌ ¿À¸£¸ç, µÎÅë µîÀÇ Áõ»óÀÌ ³ªÅ¸³¯ ¶§¿¡´Â Åõ¿©¸¦ ÁßÁö ÇÏ°í ¾à»ç ¶Ç´Â ÀÇ»ç¿Í »óÀÇÇÒ °Í.
2) ¼öÀϰ£ º¹¿ëÇÏ¿©µµ Áõ»óÀÇ °³¼±ÀÌ ¾øÀ» °æ¿ì¿¡´Â º¹¿ëÀ» ÁßÁöÇϰí ÀÇ»ç, ¾à»ç¿Í »óÀÇÇÒ °Í.
3) Àå±â°£ °è¼ÓÇÏ¿© º¹¿ëÇÏÁö ¸» °Í.
4) Àå±â°£ °è¼ÓÇÏ¿© º¹¿ëÇÒ ¶§¿¡´Â ÀÇ»ç, ¾à»ç¿Í »óÀÇÇÒ °Í.
<´ÙÀ½°ú °°Àº °æ¿ì ÀÌ ¾àÀÇ º¹¿ëÀ» Áï°¢ ÁßÁöÇϰí ÀÇ»ç, ¾à»ç¿Í »óÀÇÇÒ °Í.>
1) º»Á¦ÀÇ º¹¿ë¿¡ ÀÇÇØ ´¢·®ÀÌ °¨¼ÒÇϰųª, ¾ó±¼À̳ª ¼Õ¹ßÀÌ º×°Å³ª, ´«²¨Ç®ÀÌ ¹«°Ì°Å³ª, ¼ÕÀÌ ±»¾îÁö°Å³ª, Ç÷¾ÐÀÌ ¿À¸£°Å³ª, µÎÅë µîÀÇ Áõ»óÀÌ ³ªÅ¸³ª´Â °æ¿ì¿¡´Â º¹¿ëÀ» ÁßÁöÇϰí ÀÇ»ç, ¾à»ç¿¡°Ô »ó´ãÇÒ °Í.
2) À§¾Ëµµ½ºÅ×·ÐÁõ: 1ÀÏ ÃÖ´ë º¹¿ë·®ÀÌ ±Û¸®½Ã¸®Áø»ê À¸·Î¼ 40mg ÀÌ»óÀÎ Á¦Á¦´Â Àå±â¿¬¿ëÇÒ °æ¿ì ÀúÄ®·ýÇ÷Áõ , Ç÷¾Ð»ó½Â , ³ªÆ®·ý ü¾×ÀÇ Àú·ù, ºÎÁ¾ , üÁßÁõ°¡ µîÀÇ À§¾Ëµµ½ºÅ×·ÐÁõÀÌ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¹Ç·Î, °üÂû(Ç÷û Ä®·ýÄ¡ÀÇ ÃøÁ¤)À» ÃæºÐÈ÷ Çϰí ÀÌ»óÀÌ ÀÎÁ¤µÇ´Â °æ¿ì º¹¿ëÀ» ÁßÁöÇÒ °Í.
3) ±Ùº´Áõ : ÀúÄ®·ýÇ÷Áõ ÀÇ °á°ú·Î¼ ±Ùº´Áõ ÀÌ ³ªÅ¸³ª´Â °æ¿ì°¡ ÀÖÀ¸¹Ç·Î, °üÂûÀ» ÃæºÐÈ÷ ÇÏ°í ¹«·Â °¨, »çÁö°æ·Ã , ¸¶ºñ µîÀÇ ÀÌ»óÀÌ È®ÀεǴ °æ¿ì¿¡´Â º¹¿ëÀ» ÁßÁöÇÒ °Í.
<º¹¿ë Áß ¶Ç´Â º¹¿ë ÈÄ´Â ´ÙÀ½ »çÇ×À» ÁÖÀÇÇÒ °Í.>
Ä®·ýÇÔÀ¯Á¦Á¦, °¨ÃÊ ÇÔÀ¯Á¦Á¦, ±Û¸®½Ã¸®Áø»ê ȤÀº ±× ¿°·ù ÇÔÀ¯Á¦Á¦, ·çÇÁ°èÀÌ´¢Á¦(Ǫ·Î¼¼¹Ìµå , ¿¡Å¸Å©¸°»ê ) ¶Ç´Â Ä¡¾ÆÁöµå°è ÀÌ´¢Á¦(Æ®¸®Å¬·Î¸£¸ÞÄ¡¾ÆÁöµå)¿Í º´¿ë½Ã À§¾Ëµµ½ºÅ×·ÐÁõÀ̳ª ÀúÄ®·ýÇ÷Áõ À¸·Î ÀÎÇÏ¿© ±Ùº´Áõ ÀÌ ³ªÅ¸³ª±â ½¬¿ì¹Ç·Î ½ÅÁßÈ÷ Åõ¿©ÇÒ °Í.
Off-label Usage
[Á¶È¸]
Á¤º¸¿ä¾à
µå·°ÀÎÆ÷ ÀǾàǰ ¿ä¾à/»ó¼¼Á¤º¸
ÄÚµå ¹× ºÐ·ùÁ¤º¸
Á¦Ç°Á¤º¸
º¹¾àÁ¤º¸
Ç׸ñ
³»¿ë
LACTmed ¹Ù·Î°¡±â
[¹Ù·Î°¡±â]
¾à¸®ÀÛ¿ë
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
Ãà¾àº¹¾àÁöµµ
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
º¹¾àÁöµµ
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
ÀӺο¡´ëÇÑÅõ¿©
*
ÀüüÀӽŠ±â°£º°·Î ¿©·¯µî±ÞÀÌ Á¸ÀçÇÒ ¼ö ÀÖÀ¸¸ç °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ º¸¿©Áý´Ï´Ù. ´Ü, º¹ÇÕÁ¦ÀÇ °æ¿ì ¸ðµç º¹ÇÕÁ¦¼ººÐ¿¡ ´ëÇÑ ÀÓºÎÅõ¿©µî±ÞÀÌ Ç¥½ÃµÈ°ÍÀº Àý´ë ¾Æ´Ï¸ç Ç¥½ÃµÈ°ÍÁß¿¡ °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ ³ªÅ¸³³´Ï´Ù.
 
FDA : Aµî±Þ
(thiamine; )
*
»ó±â ÀÓºÎÅõ¿©¿¡ ´ëÇÑ Á¤º¸´Â Àü»êó¸® µÇ¸é¼ ÀÔ·Â ¿À·ù °¡´É¼ºÀÌ Á¸ÀçÇÕ´Ï´Ù. ¿À·ù °¡´É¼ºÀ» ÃÖ¼ÒÈÇϱâ À§ÇÏ¿© ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸³ª, ±× Á¤È®¼º¿¡ ´ëÇÏ¿© È®½ÅÀ» µå¸± ¼ö ¾ø½À´Ï´Ù. ÀÌ¿¡ ´ëÇØ ȸ»ç´Â Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù.
*
¹Ýµå½Ã °ø½Å·Â ÀÖ´Â ¹®ÇåÀ» ´Ù½Ã Çѹø Âü°í ÇϽñ⠹ٶó¸ç ÀÇ»ç ¶Ç´Â ¾à»çÀÇ ÆÇ´Ü¿¡ µû¶ó Åõ¿©¿©ºÎ°¡ °áÁ¤µÇ¾î¾ß ÇÕ´Ï´Ù.
Pharmacokinetics
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸
[º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸]
º¸°ü»ó ÁÖÀÇ
Á¶Á¦½Ã ÁÖÀÇ
½É»çÁ¤º¸
ÇмúÁ¤º¸
Ç׸ñ
³»¿ë
DUR (ÀǾàǰ»ç¿ëÆò°¡)
º´¿ë±Ý±â :
°í½ÃµÈ º´¿ë±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[»óÈ£ÀÛ¿ë/º´¿ë±Ý±â°Ë»ö]
¿¬·É´ë±Ý±â :
°í½ÃµÈ ¿¬·É±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[¿¬·É´ë±Ý±â»ó¼¼°Ë»ö]
Mechanism of Action
Thiamine¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ It is thought that the mechanism of action of thiamine on endothelial cells is related to a reduction in intracellular protein glycation by redirecting the glycolytic flux.
Pharmacology
Thiamine¿¡ ´ëÇÑ Pharmacology Á¤º¸ Thiamine is a vitamin with antioxidant, erythropoietic, cognition-and mood-modulatory, antiatherosclerotic, putative ergogenic, and detoxification activities. Thiamine has been found to protect against lead-induced lipid peroxidation in rat liver and kidney. Thiamine deficiency results in selective neuronal death in animal models. The neuronal death is associated with increased free radical production, suggesting that oxidative stress may play an important early role in brain damage associated with thiamine deficiency. Thiamine plays a key role in intracellular glucose metabolism and it is thought that thiamine inhibits the effect of glucose and insulin on arterial smooth muscle cell proliferation. Inhibition of endothelial cell proliferation may also promote atherosclerosis. Endothelial cells in culture have been found to have a decreased proliferative rate and delayed migration in response to hyperglycemic conditions. Thiamine has been shown to inhibit this effect of glucose on endothelial cells.
Protein Binding
Thiamine¿¡ ´ëÇÑ ´Ü¹é°áÇÕ Á¤º¸ 90-94%
Absorption
Thiamine¿¡ ´ëÇÑ Absorption Á¤º¸ Absorbed mainly from duodenum, by both active and passive processes
Pharmacokinetics
Thiamine HClÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
Èí¼ö :
°æ±¸ : ÃÖ´ëÈí¼ö·® : 8-15 mg/day
±ÙÀ°ÁÖ»ç : ½Å¼ÓÇÏ°í ¿ÏÀüÇÏ°Ô Èí¼öµÈ´Ù.
ºÐÆ÷ : Ãּҿ䱸·® (¾à 1 mg/day)À» Ãʰú ¼·Ãë½Ã Á¶Á÷ ÀúÀå¿¡ Æ÷Ȱ¡ ³ªÅ¸³´Ù.
¼Ò½Ç : °úÀ× ¼·ÃëµÈ ¾çÀº ´¢¸¦ ÅëÇØ ¹è¼³µÈ´Ù.
Biotransformation
Thiamine¿¡ ´ëÇÑ Biotransformation Á¤º¸ Hepatic
Toxicity
Thiamine¿¡ ´ëÇÑ Toxicity Á¤º¸ Thiamine toxicity is uncommon; as excesses are readily excreted, although long-term supplementation of amounts larger than 3 gram have been known to cause toxicity. Oral mouse LD50 = 8224 mg/kg, oral rat LD50 = 3710 mg/kg.
Drug Interactions
Thiamine¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Not Available
CYP450 Drug Interaction
[CYP450 TableÁ÷Á¢Á¶È¸]
Drug Target
[Drug Target]
Description
Thiamine¿¡ ´ëÇÑ Description Á¤º¸ 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2- hydroxyethyl)-4-methylthiazolium chloride. [PubChem]
Drug Category
Thiamine¿¡ ´ëÇÑ Drug_Category Á¤º¸ Anti-inflammatory AgentsEssential VitaminVitamin B ComplexVitamins (Vitamin B Complex)
Smiles String Canonical
Thiamine¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ CC1=NC=C(C[N+]2=CSC(CCO)=C2C)C(N)=N1
Smiles String Isomeric
Thiamine¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ CC1=NC=C(C[N+]2=CSC(CCO)=C2C)C(N)=N1
InChI Identifier
Thiamine¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/C12H17N4OS/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15)/q+1/f/h13H2
Chemical IUPAC Name
Thiamine¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol
»ç¿ëÀÚÄÁÅÙÃ÷
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2023-04-04
º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
¾Ë¸²
»ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.
°æ°í
µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù.
Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â
Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡± ¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
ÀüÈ: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÑ Àüü µ¥ÀÌÅ͸¦ º¸½Ã·Á¸é
¿©±â ·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
º´¿ë±Ý±â ¹× ƯÁ¤¿¬·É´ë ±Ý±â ¼ººÐ
[ÀǾàǰº´¿ë/¿¬·É´ë±Ý±â °í½Ã±Ù°Å·Î ¹Ù·Î°¡±â] Á¦¸ñ ¾øÀ½
2008³â 8¿ù 1ÀÏ ¾à°¡ÈÀÏ»ó 8¿ù´Þ ½Å±ÔµîÀç ¹× »èÁ¦µÇ´Â ǰ¸ñ Æ÷ÇÔÇÑ º´¿ë¿¬·É ±Ý±â ǰ¸ñ¸®½ºÆ® ±âÁØ
1. ÇöÀç °Ë»öÇÑ Á¦Ç°¿¡ ´ëÇÑ º´¿ë±Ý±â Á¦Ç° Á¸Àç¿©ºÎ ¹× °Ë»ö
ÇöÀç ÀÌÁ¦Ç°¿¡ ´ëÇÑ º´¿ë±Ý±â¿¡ ÇØ´çÇϴ û±¸Äڵ庰 Á¦Ç°³»¿ª °øÁö³»¿ëÀÌ ¾ø½À´Ï´Ù
2. ¿¬·É´ë±Ý±â Á¸Àç¿©ºÎ
ÇöÀç ÀÌÁ¦Ç°¿¡ ´ëÇÑ ¿¬·É±Ý±â¿¡ ÇØ´çÇϴ û±¸Äڵ庰 °øÁö³»¿ëÀÌ ¾ø½À´Ï´Ù